Emergency department revisits and hospital readmissions following a fall-related emergency department presentation in older adults: a systematic review and meta-analysis
Abstract
Background: Falls are a leading cause of emergency department (ED) visits in older adults, yet subsequent trajectories of acute care use remain poorly characterised. We aimed to estimate pooled proportions of ED revisits and hospital readmissions at multiple follow-up intervals within 1 year.
Methods: In this systematic review and meta-analysis (PROSPERO: CRD420251167449), we searched PubMed, Embase and Scopus from inception to 30 November 2025 for observational studies including adults aged ≥65 years presenting to the ED after an index fall. Eligible studies reported ED revisits and/or hospital readmissions within 1 year. Two reviewers independently screened studies, extracted data and assessed risk of bias using the Newcastle-Ottawa Scale. Random-effects meta-analyses of proportions were conducted for each follow-up interval.
Results: Nineteen studies (20 publications) were included, with overall low to moderate risk of bias. The cumulative proportions of patients experiencing an ED revisit increased with longer follow-up, from 3.9% within 3 days to 8.8% within 7 days, 15.0% within 30 days and 21.7% within 90 days (single study), reaching 37.5% at 6 months and 41.3% at 12 months. Hospital readmissions similarly increased from 10.4% at 30 days to 30.4% at 6 months and 31.9% at 12 months (single study). Substantial heterogeneity was observed across several pooled analyses.
Conclusion: A fall-related ED presentation is associated with substantial cumulative acute care use…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.